LCL161
Phase 1- Indications
- Small cell lung cancer, Gynecologic cancer
Company intelligence / Profile preview
SCRI Development Innovations
Nashville, Tennessee, United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Phase 1
01
Overview
SCRI Development Innovations is a global full-service oncology-focused contract research organization specializing in designing and executing clinical trials. It leverages physician leadership and advanced data integration technologies to accelerate timelines for sponsors. The company has contributed to pivotal research leading to many FDA-approved cancer therapies and collaborates with major biopharma partners on early-phase through late-stage studies.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateCell therapy
- Industry
- Contract Research Organization
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Daiichi Sankyo (strategic collaboration on early-stage oncology drug development)AstraZeneca (collaboration focused on technology enhancements in trial delivery)IQVIA (joint operational model "Accelero" for accelerating U.S. trial activation/recruitment)
Beyond the preview
Go deeper on SCRI Development Innovations.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SCRI Development Innovations.